Aniridic Fibrosis Syndrome
- PMID: 32119423
- Bookshelf ID: NBK554536
Aniridic Fibrosis Syndrome
Excerpt
Aniridic fibrosis syndrome was first described by Tsai et al. in 2005. It is a rare complication of invasive intraocular surgery (especially cataract extraction with intraocular lens implantation) that may occur in patients with congenital aniridia. It is characterized by a progressive fibrotic membrane within the anterior chamber that occurs after ocular surgery. The membrane may grow over the ciliary body (leading to hypotony), disrupt the placement of intraocular lenses (IOLs), and contribute to retinal pathologies. Those who are affected typically have a history of multiple ocular surgeries to address sequela associated with the underlying congenital aniridia. At present, there are seventeen reported cases with ages ranging from eight months to 71 years.
Aniridic fibrosis syndrome occurs in the setting of congenital aniridia or the absence of the iris. Aniridia is an intricate congenital syndrome that can arise in an inherited or sporadic manner. The iris is responsible for regulating the amount of light that enters the posterior structures of the eye. In aniridia, the iris may be completely or partially absent and may be associated with other ocular manifestations, most commonly foveal hypoplasia and nystagmus. Other ocular manifestations may include glaucoma, cataract formation, keratopathy, and optic nerve coloboma with possible hypoplasia. These diseases may require surgical intervention and the insertion of implantable devices. Aniridia and its potential ocular comorbidities can result in poor visual acuity, typically 20/100 to 20/200, with foveal hypoplasia as the most significant limiting factor for these patient’s visual acuity. Aniridia is most commonly associated with various PAX6 gene mutations, and the specific mutation can have considerable effects on the observed phenotype and resultant pathologies. Some PAX6 mutations may also be part of various clinical syndromes (e.g., WAGR, or WAGRO syndromes), but other genetic mutations (e.g., FOXC1, PITX2, PITX3) and sporadic cases have been reported to cause aniridia.
Copyright © 2025, StatPearls Publishing LLC.
Conflict of interest statement
Sections
- Continuing Education Activity
- Introduction
- Etiology
- Epidemiology
- Pathophysiology
- Histopathology
- History and Physical
- Evaluation
- Treatment / Management
- Differential Diagnosis
- Prognosis
- Complications
- Deterrence and Patient Education
- Pearls and Other Issues
- Enhancing Healthcare Team Outcomes
- Review Questions
- References
Similar articles
-
[Aniridia syndrome: clinical findings, problematic courses and suggestions for optimization of care ("aniridia guide")].Ophthalmologe. 2014 Dec;111(12):1145-56. doi: 10.1007/s00347-014-3060-x. Ophthalmologe. 2014. PMID: 25475188 German.
-
A progressive anterior fibrosis syndrome in patients with postsurgical congenital aniridia.Am J Ophthalmol. 2005 Dec;140(6):1075-9. doi: 10.1016/j.ajo.2005.07.035. Am J Ophthalmol. 2005. PMID: 16376654
-
Morphometric analysis of the lens in human aniridia and mouse Small eye.Exp Eye Res. 2021 Feb;203:108371. doi: 10.1016/j.exer.2020.108371. Epub 2020 Nov 26. Exp Eye Res. 2021. PMID: 33248069 Free PMC article.
-
Clinical and molecular aspects of congenital aniridia - A review of current concepts.Indian J Ophthalmol. 2022 Jul;70(7):2280-2292. doi: 10.4103/ijo.IJO_2255_21. Indian J Ophthalmol. 2022. PMID: 35791108 Free PMC article. Review.
-
Congenital aniridia - A comprehensive review of clinical features and therapeutic approaches.Surv Ophthalmol. 2021 Nov-Dec;66(6):1031-1050. doi: 10.1016/j.survophthal.2021.02.011. Epub 2021 Mar 4. Surv Ophthalmol. 2021. PMID: 33675823 Review.
References
-
- Tsai JH, Freeman JM, Chan CC, Schwartz GS, Derby EA, Petersen MR, Holland EJ. A progressive anterior fibrosis syndrome in patients with postsurgical congenital aniridia. Am J Ophthalmol. 2005 Dec;140(6):1075-9. - PubMed
-
- Bakhtiari P, Chan C, Welder JD, de la Cruz J, Holland EJ, Djalilian AR. Surgical and visual outcomes of the type I Boston Keratoprosthesis for the management of aniridic fibrosis syndrome in congenital aniridia. Am J Ophthalmol. 2012 May;153(5):967-971.e2. - PubMed
-
- Moosajee M, Hingorani M, Moore AT. PAX6-Related Aniridia. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet] University of Washington, Seattle; Seattle (WA): 2003. May 20, - PubMed
-
- Käsmann-Kellner B, Seitz B. [Aniridia syndrome: clinical findings, problematic courses and suggestions for optimization of care ("aniridia guide")]. Ophthalmologe. 2014 Dec;111(12):1145-56. - PubMed
Publication types
LinkOut - more resources
Full Text Sources